AFFX Affymetrix, Inc.

Affymetrix to Webcast Presentation at UBS Warburg Conference SANTA CLARA, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will webcast its presentation from the UBS Warburg Global Life Sciences Conference in New York City. Greg Schiffman, senior vice president and chief financial officer, will provide a Company overview at 2:00 p.m. ET on Wednesday, September 29th. An audio transmission of the presentation will be available live and by replay. To access both the live and archived webcast, please go to http://www.affymetrix.com/ and click on the "Investors" link. The archived replay will be available at approximately 5:00 p.m. ET on September 29th and will be available for seven days. About Affymetrix Affymetrix is a pioneer in creating breakthrough tools that are driving the genomic revolution. By applying the principles of semiconductor technology to the life sciences, Affymetrix develops and commercializes systems that enable scientists to improve the quality of life. The Company's customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as academic, government, and other non-profit research institutes. Affymetrix offers an expanding portfolio of integrated products and services, including its integrated GeneChip(R) brand platform to address the growing markets focused on understanding the relationship between genes and human health. Additional information on Affymetrix may be found at http://www.affymetrix.com/. DATASOURCE: Affymetrix, Inc. CONTACT: Doug Farrell, Vice President of Investor Relations of Affymetrix, Inc., +1-408-731-5285 Web site: http://www.affymetrix.com/

Copyright